Rocket Pharmaceuticals, Inc. (RCKT) stock
RCKTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.11+0.00 (0.00%)
Close on Nov 18, 2026Market cap $231.62MP/E –Yield –
Rocket Pharmaceuticals operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Rocket Pharmaceuticals's operating cash flow for the twelve months ending Jun 30, 2026 was -$170.27M. For fiscal 2025 it was -$190.01M. The highest annual figure on record is -$5.50M in fiscal 2016.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$190.01M | – |
| FY2024 | Dec 31, 2024 | -$209.72M | – |
| FY2023 | Dec 31, 2023 | -$194.92M | – |
| FY2022 | Dec 31, 2022 | -$178.14M | – |
| FY2021 | Dec 31, 2021 | -$121.16M | – |
| FY2020 | Dec 31, 2020 | -$74.64M | – |
| FY2019 | Dec 31, 2019 | -$64.66M | – |
| FY2018 | Dec 31, 2018 | -$53.79M | – |
| FY2017 | Dec 31, 2017 | -$15.96M | – |
| FY2016 | Dec 31, 2016 | -$5.50M | – |
| FY2015 | Dec 31, 2015 | -$17.42M | – |
| FY2014 | Dec 31, 2014 | -$9.74M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$39.61M | – |
| Q1 FY2026 | Mar 31, 2026 | -$45.39M | – |
| Q4 FY2025 | Dec 31, 2025 | -$34.84M | – |
| Q3 FY2025 | Sep 30, 2025 | -$50.42M | – |
| Q2 FY2025 | Jun 30, 2025 | -$48.96M | – |
| Q1 FY2025 | Mar 31, 2025 | -$55.79M | – |
| Q4 FY2024 | Dec 31, 2024 | -$46.94M | – |
| Q3 FY2024 | Sep 30, 2024 | -$52.10M | – |
| Q2 FY2024 | Jun 30, 2024 | -$53.82M | – |
| Q1 FY2024 | Mar 31, 2024 | -$56.86M | – |
| Q4 FY2023 | Dec 31, 2023 | -$29.34M | – |
| Q3 FY2023 | Sep 30, 2023 | -$57.15M | – |
| Q2 FY2023 | Jun 30, 2023 | -$50.87M | – |
| Q1 FY2023 | Mar 31, 2023 | -$57.56M | – |
| Q4 FY2022 | Dec 31, 2022 | -$56.02M | – |
| Q3 FY2022 | Sep 30, 2022 | -$43.86M | – |
| Q2 FY2022 | Jun 30, 2022 | -$39.04M | – |
| Q1 FY2022 | Mar 31, 2022 | -$39.22M | – |
| Q4 FY2021 | Dec 31, 2021 | -$30.94M | – |
| Q3 FY2021 | Sep 30, 2021 | -$27.41M | – |
| Q2 FY2021 | Jun 30, 2021 | -$38.53M | – |
| Q1 FY2021 | Mar 31, 2021 | -$24.28M | – |
| Q4 FY2020 | Dec 31, 2020 | -$13.11M | – |
| Q3 FY2020 | Sep 30, 2020 | -$17.25M | – |
| Q2 FY2020 | Jun 30, 2020 | -$22.03M | – |
| Q1 FY2020 | Mar 31, 2020 | -$22.25M | – |
| Q4 FY2019 | Dec 31, 2019 | -$19.73M | – |
| Q3 FY2019 | Sep 30, 2019 | -$10.85M | – |
| Q2 FY2019 | Jun 30, 2019 | -$18.10M | – |
| Q1 FY2019 | Mar 31, 2019 | -$15.98M | – |
| Q4 FY2018 | Dec 31, 2018 | -$20.81M | – |
| Q3 FY2018 | Sep 30, 2018 | -$11.64M | – |
| Q2 FY2018 | Jun 30, 2018 | -$9.74M | – |
| Q1 FY2018 | Mar 31, 2018 | -$11.60M | – |
| Q4 FY2017 | Dec 31, 2017 | -$5.99M | -129.0% |
| Q3 FY2017 | Sep 30, 2017 | -$4.09M | – |
| Q2 FY2017 | Jun 30, 2017 | -$2.16M | – |
| Q1 FY2017 | Mar 31, 2017 | -$3.72M | – |
| Q4 FY2016 | Dec 31, 2016 | $20.63M | – |
| Q3 FY2016 | Sep 30, 2016 | -$9.13M | – |
See a number that looks wrong?